Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line - PubMed (original) (raw)
Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line
C D Gregory et al. J Gen Virol. 1990 Jul.
Abstract
Epstein-Barr virus (EBV)-positive Burkitt's lymphoma (BL) biopsy cells and early passage BL cell lines have been reported as showing an unusual type of virus-cell interaction; at least two EBV latent proteins appear not to be expressed. Serial passage of such lines is often accompanied by a broadening of virus latent gene expression and a corresponding change in the cell surface/growth phenotype towards that shown by in vitro transformed lymphoblastoid cell lines (LCLs). The sequence of events, both viral and cellular, involved in this transition needs to be defined properly. In the present work, phenotypically distinct cell clones have been derived from early passage cultures of a BL cell line in phenotypic transition, thereby giving access to relatively stable cell populations through which the different EBV-B cell interactions within the parental line can be studied. Clones retaining the original BL biopsy cell phenotype (CD10/CD77-positive, activation antigen/adhesion molecule-negative) expressed the virus-encoded nuclear antigen EBNA 1 but not any of the other known latent proteins, EBNAs 2, 3a, 3b, 3c, -LP and latent membrane protein (LMP). Other clones which had developed an LCL-like phenotype (CD10/CD77-negative, activation antigen/adhesion molecule-positive) now expressed all the above latent proteins and also contained significant numbers of cells in lytic cycle. Phenotypic change occurring within the parental BL cell line itself was initiated in a small subpopulation of cells in which the virus-encoded proteins EBNA 2 and LMP were transiently induced to an unusually high level of expression; this was accompanied by the first detectable changes in cell surface phenotype, namely the increase of cellular adhesion molecules. Some control over EBNA 2/LMP expression then appeared to be re-imposed since the presumed clonal descendents of these cells stably expressed EBNA 2 and LMP at much reduced levels typical of those seen in conventional LCLs.
Similar articles
- Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E. Wang F, et al. J Virol. 1990 May;64(5):2309-18. doi: 10.1128/JVI.64.5.2309-2318.1990. J Virol. 1990. PMID: 2157887 Free PMC article. - Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
Allday MJ, Crawford DH, Thomas JA. Allday MJ, et al. J Gen Virol. 1993 Mar;74 ( Pt 3):361-9. doi: 10.1099/0022-1317-74-3-361. J Gen Virol. 1993. PMID: 8383171 - Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
Masucci MG, Zhang QJ, Gavioli R, De Campos-Lima PO, Murray RJ, Brooks J, Griffin H, Ploegh H, Rickinson AB. Masucci MG, et al. Int Immunol. 1992 Nov;4(11):1283-92. doi: 10.1093/intimm/4.11.1283. Int Immunol. 1992. PMID: 1282031 - T cell recognition of Epstein-Barr virus associated lymphomas.
Rickinson AB, Murray RJ, Brooks J, Griffin H, Moss DJ, Masucci MG. Rickinson AB, et al. Cancer Surv. 1992;13:53-80. Cancer Surv. 1992. PMID: 1330300 Review. - Epstein-Barr virus: a human pathogen inducing lymphoproliferation in vivo and in vitro.
Sugden B. Sugden B. Rev Infect Dis. 1982 Sep-Oct;4(5):1048-61. doi: 10.1093/clinids/4.5.1048. Rev Infect Dis. 1982. PMID: 6293034 Review.
Cited by
- Epstein-Barr virus latency type and spontaneous reactivation predict lytic induction levels.
Phan AT, Fernandez SG, Somberg JJ, Keck KM, Miranda JL. Phan AT, et al. Biochem Biophys Res Commun. 2016 May 20;474(1):71-75. doi: 10.1016/j.bbrc.2016.04.070. Epub 2016 Apr 16. Biochem Biophys Res Commun. 2016. PMID: 27091426 Free PMC article. - Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature.
Kelly GL, Stylianou J, Rasaiyaah J, Wei W, Thomas W, Croom-Carter D, Kohler C, Spang R, Woodman C, Kellam P, Rickinson AB, Bell AI. Kelly GL, et al. J Virol. 2013 Mar;87(5):2882-94. doi: 10.1128/JVI.03003-12. Epub 2012 Dec 26. J Virol. 2013. PMID: 23269792 Free PMC article. - Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.
D'Souza BN, Edelstein LC, Pegman PM, Smith SM, Loughran ST, Clarke A, Mehl A, Rowe M, Gélinas C, Walls D. D'Souza BN, et al. J Virol. 2004 Feb;78(4):1800-16. doi: 10.1128/jvi.78.4.1800-1816.2004. J Virol. 2004. PMID: 14747545 Free PMC article. - Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.
Ellis-Connell AL, Iempridee T, Xu I, Mertz JE. Ellis-Connell AL, et al. J Virol. 2010 Oct;84(19):10329-43. doi: 10.1128/JVI.00923-10. Epub 2010 Jul 28. J Virol. 2010. PMID: 20668090 Free PMC article. - Epstein-Barr virus latency programs dynamically sensitize B cells to ferroptosis.
Burton EM, Voyer J, Gewurz BE. Burton EM, et al. Proc Natl Acad Sci U S A. 2022 Mar 15;119(11):e2118300119. doi: 10.1073/pnas.2118300119. Epub 2022 Mar 11. Proc Natl Acad Sci U S A. 2022. PMID: 35275790 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials